Physician profile
Jeffrey P Flash
NPI 1255318937
$114,033.85
in general payments reported to CMS, 2019-2025
18 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $210 · 2021: $13.90 · 2022: $339 · 2023: $790 · 2024: $111K · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $110K · Food and Beverage: $2,204 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $110,400.00 |
| Food and Beverage | $2,203.68 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $110,810.71 | 2023-2024 | |
| Treace Medical Concepts, INC. | $995.20 | 2023-2025 | |
| Averitas Pharma INC. | $587.26 | 2023-2025 | Qutenza |
| Horizon Therapeutics Plc | $429.77 | 2019-2021 | |
| Triad Life Sciences INC. | $221.42 | 2022 | |
| Organogenesis INC. | $182.01 | 2019-2022 | |
| Bone Support INC. | $154.86 | 2024 | Cerament G, Ceramentbone Void Filler |
| Pacira Pharmaceuticals Incorporated | $118.25 | 2019 | |
| Melinta Therapeutics, LLC | $116.11 | 2019 | |
| Trilliant Surgical LLC. | $107.63 | 2019 | |
| Smith+Nephew, INC. | $69.09 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $55.65 | 2023 | Seglentis |
| Zyla Life Sciences, INC. | $54.30 | 2019 | |
| Grt US Holding, INC. | $52.12 | 2022 | |
| Djo, LLC | $36.00 | 2024 | Dr Comfort |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $16.44 | 2019 | |
| Aroa Biosurgery Incorporated | $15.81 | 2020 | |
| Paragon 28, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Flash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.